| Tina Harrach Denetclaw, PHARMD | |
|
23 Kirkpatrick Dr, El Sobrante, CA 94803-1415 | |
| (510) 758-6407 | |
| Not Available |
| Full Name | Tina Harrach Denetclaw |
|---|---|
| Gender | Female |
| Speciality | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist |
| Location | 23 Kirkpatrick Dr, El Sobrante, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225494768 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1835P0018X | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist | RPH 44718 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Tina Harrach Denetclaw, PHARMD 23 Kirkpatrick Dr, El Sobrante, CA 94803-1415 Ph: (510) 758-6407 | Tina Harrach Denetclaw, PHARMD 23 Kirkpatrick Dr, El Sobrante, CA 94803-1415 Ph: (510) 758-6407 |
News Archive
"The Philippine President has signed into law a family-planning bill that was blocked by the Catholic Church for more than a decade," Al Jazeera reports (12/28). "President Benigno Aquino III signed into a law a bill that promotes contraception and sex education in schools," the Wall Street Journal writes.
Ortho Clinical Diagnostics today announced it will present seven scientific posters on its assays and display six products at its booth at the 2016 American Association for Clinical Chemistry annual meeting.
Less than one-third of patients with glaucoma talk to their doctor about the costs of medications needed to control their disease, reports a study in the December issue of Optometry and Vision Science, the official journal of the American Academy of Optometry.
Yale University scientists have developed a novel chemical process that may lead to the creation of a new class of antibiotics.
KemPharm, Inc. today announced positive results from a Phase 1 clinical trial of KP106, its novel prodrug for attention-deficit hyperactivity disorder (ADHD). KP106, a new chemical entity (NCE) composed of the active pharmaceutical compound d-amphetamine and a ligand, was created using KemPharm's proprietary Ligand Activated Therapy (LAT) prodrug approach.
› Verified 3 days ago
Wen-wen Yang, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5352 Debra Ln, El Sobrante, CA 94803 Phone: 510-520-3820 | |
Dr. Sandeep Kaur, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5398 Country View Dr, El Sobrante, CA 94803 Phone: 510-207-2906 | |
Dr. Thoa Thi Trinh, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3630 San Pablo Dam Rd, El Sobrante, CA 94803 Phone: 510-758-2365 Fax: 510-758-8590 |